Healthy Ages 18-45 - Earn up to $900
If you've previously submitted an application, call 417-831-2048 to enroll. Or submit your application now.
Participant Requirements: Men and Women, ages 18-45, non-tobacco users for 3 months. . Females must be using a medically acceptable contraceptive method such as double barrier (condom, diaphragm or cervical cap with spermicidal foam, gel or cream); IUD, hormonal, vasectomized partner, alternative lifestyle, abstinence or be sterilized by bilateral tubal ligation, bilateral insertion of Essure®, hysterectomy and/or bilateral oophorectomy or be postmenopausalfor at least 1 year. BMI (Body Mass Index) must be between 18-35.
What: This clinical research trial is evaluating the metabolic rate, absorption and tolerability of an investigational vs. a marketed medication used to treat bladder spasms and other gastrointestinal conditions. This medication will be delivered via IV injection.
When: This study will consist of a 1 long weekend stay. Study dates are as follows:
Group 1Visit Dates
How Much: $900 on Friday, November 6, 2020
Physical: Tuesday, October 20, 2020
All study dates are tentative and subject to change.
We will update the study list every Wednesday. Be sure to check with us either by calling or by looking online. Call (417) 831-2048 or come by 1820 West Mt. Vernon for more information. Office hours are Monday through Friday, 8:00 a.m. to 5:00 p.m.
At QPS, the health and safety of our participants, employees, families and communities is of the utmost importance during this time and will be enrolling studies as soon as possible!
Due to the COVID-19 Pandemic, you are now able to sign up for this particular study by clicking the "Sign-Up Button" below and a QPS Recruiting Coordinator will contact you directly.
If you haven’t already, please fill out an application and a QPS Recruiting Coordinator will contact you
Don't forget our REFERRAL PROGRAM. Earn at least $200 for every new participant you refer who completes a study.**No referral bonuses are paid out for outpatient vaccine studies.